Laboratory Monitoring for Methotrexate Overdose (90 mg over 4 days)
Immediate comprehensive laboratory evaluation is essential, as this represents a significant overdose (typical weekly dosing is 7.5-25 mg) with potential for life-threatening toxicity including pancytopenia, hepatotoxicity, and renal failure. 1
Essential Immediate Laboratory Tests
Hematologic Monitoring (Priority #1)
- Complete blood count (CBC) with differential and platelet count - must be obtained immediately and repeated daily 2, 3, 1
- Myelosuppression is the leading cause of methotrexate-related fatalities (67 of 164 reported deaths) 2
- Pancytopenia can occur even after single overdoses and may manifest 4-6 weeks after exposure 2
- Critical thresholds requiring intervention: WBC <3,000/mm³, absolute neutrophil count <1,000/mm³, platelets <100,000/mm³ 4
Renal Function Assessment (Priority #2)
- Serum creatinine and BUN - obtain immediately 2, 3, 1
- Calculate creatinine clearance or GFR - essential as 85% of methotrexate is renally excreted 2
- Urinalysis - check for crystalluria 3
- Renal impairment dramatically increases toxicity risk and delays methotrexate elimination 2
Hepatic Function (Priority #3)
- Liver function tests: ALT, AST, alkaline phosphatase, serum albumin - obtain immediately 2, 3, 1
- Monitor every 2-4 weeks initially if elevated 5
- Hepatotoxicity accounts for 8 of 164 methotrexate-related deaths 2
Methotrexate Level Monitoring
- Serum methotrexate concentration - if available, obtain at least 4 hours after last dose 6, 7
- This guides leucovorin (folinic acid) rescue dosing 6, 7
- Continue monitoring until levels <0.05 µmol/L 6
Monitoring Schedule
Days 1-7 (Acute Phase):
- CBC with differential: Daily
- Renal function (creatinine, BUN): Daily
- Liver function tests: Every 2-3 days
- Methotrexate levels: Daily if available until undetectable
Weeks 2-6 (Extended Monitoring):
- CBC with differential: Twice weekly (pancytopenia can occur up to 6 weeks post-exposure) 2
- Renal and liver function: Weekly
Critical Management Considerations
Immediate Interventions
Leucovorin (folinic acid) rescue must be initiated immediately - this is the antidote for methotrexate toxicity 2, 1:
- Initial dose: 10 mg/m² or up to 100 mg/m² if methotrexate level unknown 6
- Administer every 6 hours until methotrexate levels <0.05 µmol/L 6
- Effectiveness decreases significantly if delayed >24 hours from last methotrexate dose 2
Supportive Care
- Aggressive hydration to enhance renal elimination 6, 7
- Urine alkalinization with sodium bicarbonate to prevent methotrexate precipitation in renal tubules 6
- Monitor for signs of sepsis if neutropenia develops 2
Common Pitfall
Do not wait for symptoms to appear before obtaining labs - toxic effects may not manifest for 6-23 days and include mucositis, fever, diarrhea, erythema, and ulceration 6. The patient described took approximately 3-4 times the maximum recommended weekly dose, distributed incorrectly over consecutive days rather than as a single weekly dose. This dosing error pattern is a well-documented cause of fatal toxicity 1.
Additional Monitoring if Complications Develop
- Chest X-ray and pulmonary function tests if respiratory symptoms develop (pulmonary toxicity caused 30 of 164 methotrexate deaths) 2
- Blood cultures if fever develops with neutropenia 2
Glucarpidase may be considered for severe toxicity with delayed methotrexate elimination if standard leucovorin rescue is insufficient 7.